Duration of diabetes, glycemic control, and risk of neuropathy among diabetes population in Indonesia
Innovation in Health for Society · 2025
DOI: 10.31603/ihs.13073 ↗Kurz gefasst
Fachartikel in der Zeitschrift Innovation in Health for Society, 2025. Verfasst von Andra Agnez Al Aska und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Diabetic neuropathy is a serious and common complication for individuals with Type 2 Diabetes (T2D). However, there's a scarcity of studies investigating how the duration of diabetes and glycemic control impact the development of neuropathy. This study aimed to examine the effect of diabetes duration and blood glucose levels on the risk of neuropathy in patients with T2D in Surabaya. This was an observational study utilizing a cross-sectional data collection method. Data were gathered from 150 patients between May and July 2023. Patients were categorized based on their diabetes duration (less than 5 years, 5–10 years, and greater than 10 years) and their blood glucose levels (HbA1c less than 7%, 7–10%, and greater than 10%). Neuropathy was assessed using the 10g monofilament test and the Neuropathy Disability Score (NDS). Statistical analysis involved descriptive statistics and logistic regression, with a significance level set at 0.05 for hypothesis testing. The results revealed a significantly higher risk of neuropathy in patients with T2D for more than 10 years (90%) compared to those with T2D for less than 5 years (40%). Similarly, patients with poor blood glucose control (HbA1c greater than 10%) had an 85% chance of developing neuropathy. Whereas only 30% of those with well-controlled blood glucose (HbA1c less than 7%) developed the condition. Logistic regression analysis further confirmed that both a longer diabetes duration and elevated blood glucose levels significantly increase the risk of neuropathy (p
Zitieren
APA
Aska, A. A. A., & Wardhani, M. K. (2025). Duration of diabetes, glycemic control, and risk of neuropathy among diabetes population in Indonesia. Innovation in Health for Society. https://doi.org/10.31603/ihs.13073
Vancouver
Aska AAA, Wardhani MK. Duration of diabetes, glycemic control, and risk of neuropathy among diabetes population in Indonesia. Innovation in Health for Society. 2025. doi:10.31603/ihs.13073
BibTeX
@article{Aska2025,
author = {Aska, Andra Agnez Al and Wardhani, Mira Kusuma},
title = {Duration of diabetes, glycemic control, and risk of neuropathy among diabetes population in Indonesia},
journal = {Innovation in Health for Society},
year = {2025},
doi = {10.31603/ihs.13073}
}
EUVIMED